The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruce, A. G.
Right arrow Articles by Rose, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruce, A. G.
Right arrow Articles by Rose, T. M.

The Journal of Immunology, Vol 149, Issue 4 1271-1275, Copyright © 1992 by American Association of Immunologists

ARTICLES

Oncostatin M is a differentiation factor for myeloid leukemia cells

AG Bruce, IH Hoggatt and TM Rose
Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, WA 98121.

Oncostatin M (OSM) is a 28-kDa glycoprotein produced by stimulated macrophages and T lymphocytes that inhibits the proliferation of a number of different cell lines derived from solid tumors. Analysis of both amino acid sequence and gene structure has demonstrated that OSM is a member of a cytokine family that includes leukemia inhibitory factor (LIF), IL-6, and granulocyte colony-stimulating factor (G-CSF). We demonstrate that, like LIF, IL-6 and G-CSF, OSM can induce the differentiation of the myeloblastic M1 murine leukemia cells into macrophage-like cells. The morphologic and functional changes induced by OSM are more similar to those observed with LIF and IL-6 than those induced with G-CSF. OSM can also induce the differentiation of the histiocytic U937 human leukemia cells in the presence of granulocyte- macrophage CSF, a property shared with LIF and IL-6. In murine M1 cells, binding of labeled OSM is completely inhibited by excess LIF or OSM, reflecting the binding of OSM to the high affinity form of the murine LIF receptor. In contrast, the binding of labeled OSM to human U937 leukemia cells is inhibited by OSM, but the inhibition by LIF is significantly less. These results suggest that, in human leukemia cells, OSM may act through the LIF receptor and an OSM-specific receptor. The existence of an OSM-specific receptor was confirmed by both growth inhibition and competition binding assays on A375 human melanoma cells. The growth of human A375 cells was inhibited by OSM and IL-6 but not LIF or G-CSF. Neither LIF, G-CSF, nor IL-6 could compete with the binding of labeled OSM to A375 cells.


This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
P. G. Tiffen, N. Omidvar, N. Marquez-Almuina, D. Croston, C. J. Watson, and R. W. E. Clarkson
A Dual Role for Oncostatin M Signaling in the Differentiation and Death of Mammary Epithelial Cells in Vivo
Mol. Endocrinol., December 1, 2008; 22(12): 2677 - 2688.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Gurbuxani, P. Vyas, and J. D. Crispino
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome
Blood, January 15, 2004; 103(2): 399 - 406.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Tanaka, Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki, and A. Miyajima
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
Blood, November 1, 2003; 102(9): 3154 - 3162.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. T. Richardson, R. Starr, L. J. L. Angus, and D. J. Hilton
A Somatic Cell Genetic System for Dissecting Hemopoietic Cytokine Signal Transduction
J. Biol. Chem., July 5, 2002; 277(28): 25624 - 25630.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kawashima, K. Murata, S. Akira, Y. Tonozuka, Y. Minoshima, S. Feng, H. Kumagai, H. Tsuruga, Y. Ikeda, S. Asano, et al.
STAT5 Induces Macrophage Differentiation of M1 Leukemia Cells Through Activation of IL-6 Production Mediated by NF-{kappa}B p65
J. Immunol., October 1, 2001; 167(7): 3652 - 3660.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Ihn and K. Tamaki
Oncostatin M Stimulates the Growth of Dermal Fibroblasts Via a Mitogen-Activated Protein Kinase-Dependent Pathway
J. Immunol., August 15, 2000; 165(4): 2149 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Nakayama, T. Hara, M. Hibi, T. Hirano, and A. Miyajima
A Novel Oncostatin M-inducible Gene OIG37 Forms a Gene Family with MyD118 and GADD45 and Negatively Regulates Cell Growth
J. Biol. Chem., August 27, 1999; 274(35): 24766 - 24772.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. P. De Miguel, J. Regadera, F. Martinez-Garcia, M. Nistal, and R. Paniagua
Oncostatin M in the Normal Human Testis and Several Testicular Disorders
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 768 - 774.
[Abstract] [Full Text]

Home page
 BloodHome page
M. Tanaka, T. Hara, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Miyajima
Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor beta  Subunit
Blood, February 1, 1999; 93(3): 804 - 815.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. I. Smith, D. Weil, G. R. Johnson, A. W. Boyd, and C. L. Li
Expression of the Wilms' Tumor Suppressor Gene, WT1, Is Upregulated by Leukemia Inhibitory Factor and Induces Monocytic Differentiation in M1 Leukemic Cells
Blood, February 1, 1998; 91(3): 764 - 773.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. A. Habecker, A. J. Symes, N. Stahl, N. J. Francis, A. Economides, J. S. Fink, G. D. Yancopoulos, and S. C. Landis
A Sweat Gland-derived Differentiation Activity Acts through Known Cytokine Signaling Pathways
J. Biol. Chem., November 28, 1997; 272(48): 30421 - 30428.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Ichihara, T. Hara, H. Kim, T. Murate, and A. Miyajima
Oncostatin M and Leukemia Inhibitory Factor Do Not Use the Same Functional Receptor in Mice
Blood, July 1, 1997; 90(1): 165 - 173.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Auguste, C. Guillet, M. Fourcin, C. Olivier, J. Veziers, A. Pouplard-Barthelaix, and H. Gascan
Signaling of Type II Oncostatin M Receptor
J. Biol. Chem., June 20, 1997; 272(25): 15760 - 15764.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Korzus, H. Nagase, R. Rydell, and J. Travis
The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression
J. Biol. Chem., January 10, 1997; 272(2): 1188 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman
Dual Oncostatin M (OSM) Receptors. CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION
J. Biol. Chem., December 20, 1996; 271(51): 32635 - 32643.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
J. C. Conover, N. Y. Ip, W. T. Poueymirou, B. Bates, M. P. Goldfarb, T. M. DeChiara, and G. D. Yancopoulos
Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells
Development, November 1, 1993; 119(3): 559 - 565.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.